Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

Purpose and Objective(s): We sought to analyze the long-term follow-up of patients treated with hypofractionated, stereotactic radiotherapy (HSRT) for oligometastases from malignancies other than breast or prostate cancer.Materials and Methods: From 2001 to 2006, 82 cancer patients with 1–5 radiogra...

Full description

Bibliographic Details
Main Authors: Khush S. Aujla, Alan W. Katz, Deepinder P. Singh, Paul Okunieff, Michael T. Milano
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Oncology
Subjects:
oligometastases
radiotherapy
metastases
stereotactic radiation
survival
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00111/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00111/full

Similar Items